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1. Introduction 
Tinnitus is defined as the perception of abnormal noise by the patient in the absence of an 
external acoustic source. It may be described as a ringing, whistling, buzzing, roaring, or 
clicking sound, although any type of sound may be reported. Tinnitus may be unilateral or 
bilateral, and can be described as occurring within the head or as a distant sound 1. It may 
occur constantly or intermittently. Tinnitus severity may vary considerably, ranging from a 
minor annoyance for the patient to distressing enough for certain patients to consider 
suicide 2.  
Tinnitus appears to be a very common symptom, with a reported prevalence ranging from 
10 - 25 % 3,4. Of the 35 - 50 million adults with this symptom, approximately 12 million visit 
a physician; 2 - 3 million of these patients are severely impacted by tinnitus 5. Furthermore, 
these patients often have numerous associated comorbidities including anxiety, depression, 
and reduced general health 6-9. Tinnitus occurs more frequently in Caucasians, men, and 
older age groups 10. Other reported risk factors include exposure to loud noise, hearing loss, 
smoking, and hypertension 11,12. Tinnitus has also been reported in approximately 36% of 
children, but often goes undocumented due to the infrequency of their spontaneously 
reporting it 13. 
Numerous hypotheses have been developed for the pathophysiology of tinnitus; however, a 
precise mechanism has not been established 14. Tinnitus may arise from any abnormality of 
the neural pathway from the cochlear neural axis to the auditory cortex. Proposed etiologies 
include damage to hair cells with accompanying excess stimulation of auditory nerves, 
increased activity in the auditory complex, and excessively active auditory nerves 3,15. 
Multiple mechanisms likely account for tinnitus because of the complexity of the hearing 
pathways, and thus this symptom is non-specific. 
Several classification types have been used to described tinnitus. One such method 
classifies tinnitus as objective or subjective. Objective tinnitus indicates that the sound 
may be heard by the physician by auscultation with a stethoscope over the head and neck 
adjacent to the patient's ear 3. Subjective tinnitus is considerably more common, and is 
only perceived by the patient. This chapter will review the differential diagnosis of 
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2. Objective tinnitus 
Objective tinnitus, occasionally referred to as somatosounds, is audible to the physician by 
use of a stethoscope or Doppler 15. The tinnitus is often characterized by the patient as a 
clicking or pulsing sound. The cause is often due to a vascular abnormality, which may be 
arterial or venous in etiology 1. Additional causes include neurologic lesions or eustachian 
tube dysfunction 15.  
2.1 Vascular causes 
i. Arterial sources. Arteriovenous shunts include both arteriovenous malformations and 
arteriovenous fistulas, and represent an important cause of tinnitus that is essential to 
recognize in the emergency department 1. Congenital arteriovenous malformations are 
generally asymptomatic and are uncommon causes of tinnitus, whereas acquired 
arteriovenous shunts are more likely to be symptomatic. Approximately 10 -15 % of 
intracranial arteriovenous fistula are dural, but are more often responsible for tinnitus than 
neck or cerebral arteriovenous shunts 16. Dural arteriovenous fistulas likely arise due to 
dural venous sinus thrombosis that is most often due to trauma, but may also be secondary 
to infections, neoplasms, or surgery 17. Mortality from hemorrhage of a dural arteriovenous 
fistula ranges from 10 - 20% 17; thus, appropriate diagnosis by emergency physicians is 
essential. 
A second significant cause of acquired arteriovenous shunt that may cause tinnitus is a 
paraganglioma in the temporal bone, classified as either a glomus jugulare or glomus 
typanicum tumor 15. Such tumors often cause the patient to perceive a constant blowing 
sound. Additional symptoms that may occur as the tumor enlarges include hearing loss, and 
deficits in cranial nerves VII - XII. These tumors are occasionally visualized as a vascular 
mass behind the tympanic membrane 15. 
Rarely, tinnitus may be caused by dissecting aneurysms of the of the internal auditory canal 
or the vertebral artery 17. Additional symptoms that may occur are pain, Horner's syndrome, 
cranial nerve deficits, subarachnoid hemorrhage, and transient ischemic attacks. 
Vasculopathies that predispose individuals to this condition include Marfan syndrome, 
osteogenesis imperfecta, and fibromuscular dysplasia 17.  
Tinnitus may occasionally be the presenting symptom of atherosclerosis in the carotid artery 
17,18. The source of the somatosounds is stenosis in regions of the carotid artery that result in 
blood flow turbulence. Associated risk factors are those typical for atherosclerosis and 
include older age, smoking, diabetes, hyperlipidemia, and hypertension. Carotid bruits have 
been reported in patients with this source of tinnitus 18. Tinnitus may also result from 
arterial bruits in other vessels in the temporal bone including branches of the external 
carotid, basilar, vertebral arteries, and vascular abnormalities located in the auditory canal 
15,19. These patients generally lack other otologic symptoms such as vertigo, hearing loss, 
otalgia, and symptoms of aural fullness 15. 
ii. Venous sources. Tinnitus may also arise from venous sources. A venous origin of tinnitus 
may be differentiated from an arterial source by application of pressure on the ipsilateral 
jugular vein; this maneuver results in cessation of the tinnitus from venous sources 17. 
The most important etiology of venous causes of tinnitus is pseudotumor cerebri, also called 
idiopathic intracranial hypertension. Pseudotumor cerebri classically occurs in young, 
obese, women. Pulsatile tinnitus in one series was reported to occur in 60% of patients; 
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accompanying symptoms include headache, visual disturbances, and retrobulbar pain 20. 
Indeed, the combination of headache with pulsatile tinnitus is fairly specific for the 
diagnosis of pseudotumor cerebri 20-22. The most common signs on physical exam include 
papilledema, loss of visual fields, and cranial nerve VI palsy. Occasionally, pseudotumor 
cerebri has been reported in the absence of papilledema 22-24. Untreated pseudotumor cerebri 
may lead to permanent vision loss 25. 
Venous hums are another source of tinnitus. They may be heard in patients with 
hypertension, which may be systemic or intracranial 15. Another cause of venous hum 
tinnitus is a dehiscent jugular bulb, an aberrantly high location of the jugular bulb that 
extends into the middle ear space 15. Dehiscent jugular bulb tinnitus results in a low-pitched, 
soft hum that decreases with activity, movement of the head, or application of jugular vein 
pressure. Hearing loss has been reported secondary to a dehiscent jugular bulb 26. A 
dehiscent jugular bulb may be visualized behind the tympanic membrane, and must be 
differentiated from a glomus tumor 15.     
2.2 Non-vascular causes 
Palatal myoclonus and stapedial muscle spasm are two neurologic disorders that may cause 
objective tinnitus. Palatal myoclonus is caused by inappropriate contractions of the superior 
constrictor muscles, the salpingopharyngeus, the tensor veli palatini, and the levator veli 
palatini muscles 27. The muscular contractions occur 10 - 240 times per minute, and occur 
intermittently; the objective tinnitus results from abrupt closure of the eustachian tube 28. 
This condition may occur in any age group, and may be accompanied by 
temporomandibular joint pain or occipital headaches; other reported symptoms include 
hearing loss, alteration of sounds, and the sensation of aural pressure 15. The diagnosis can 
be confirmed by viewing palatal myoclonic jerks or by listening with a Toynbee tube. This 
condition may occur secondary to other neurologic disorders such as cerebrovascular 
disease, central nervous system tumors, and multiple sclerosis 27. 
Stapedial muscle spasm is an idiopathic condition that is described as a rumbling sensation 
in the ear 15. It is often exacerbated by other noises such as speech. The diagnosis is made by 
visualizing contractions of the tympanic membrane that coincide with the sensation 
experienced by the patient. Stapedial muscle spasm is considered a benign, self-limited 
condition 15.  
Finally, dysfunction of the eustachian tube may result in objective tinnitus 15. This type of 
tinnitus is often described as a roaring sound that coincides with breathing. Patients may 
additionally report autophony and reverberation. The symptoms typically improve with 
lying down and recur after rising. It may be diagnosed by visualizing a fluttering of the 
tympanic membrane when the patient strongly inhales through the nose. This condition 
typically develops after a large weight loss of any type 15.      
3. Subjective tinnitus 
Subjective tinnitus refers to the perception of a sound that is not audible to the examiner. 
Patients describe the perceived sounds as a ringing, buzzing or clicking 29. The causes for 
subjective tinnitus generally stem from hearing loss from damage to the auditory pathway 
anywhere from the external auditory canal to the auditory nerve. 
External causes for subjective tinnitus include cerumen impaction as well as cerumen 
removal procedures 30, otitis externa 31 and temporomandibular disorders 32. The presence of 
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swelling in the external auditory canal may amplify tinnitus and must be ruled out with a 
thorough examination of the ears. 
Within the middle ear, diseases of the ossicles may result in conductive hearing loss that 
results in a subjective tinnitus 33. Patients with otosclerosis may describe a hearing loss 
which appears to improve in noisy environments. Otosclerosis may present in young or 
middle-aged adults and may be inherited in an autosomal dominant manner 34. 
Damage to cochlear hair cells encompasses some of the most common causes of subjective 
tinnitus. Noise-induced hearing loss involves damage to cochlear hair cell from exposure to 
loud sounds in the environment, ranging from close proximity to explosions to overuse of 
headphones playing music at a high volume, and the severity of the tinnitus has been found 
to be associated with the degree of hearing loss 35. These noise-induced insults may occur in 
children and young adults. In contrast, age-related hearing loss involves degeneration of 
cochlear hair cells, especially those in the higher frequency ranges, and may result in 
tinnitus corresponding to the frequencies of lost hearing 36.  
Other components of the cochlea may be affected in addition to the hair cells that can result 
in hearing loss and subjective tinnitus. In Ménière’s disease, there is an excessive 
accumulation of endolymph in the membranous labyrinth of the cochlea that leads to 
episodes of tinnitus, vertigo and progressive hearing loss 37. Tinnitus in these subjects may 
vary over time, and reported handicap resulting from tinnitus has been found to associate 
with the stage of Ménière’s disease 38. 
Compression of the auditory nerve itself may result in increased firing of afferent neurons to 
the auditory cortex, leading to a gradual or abrupt onset of subjective tinnitus. Tumors 
within the internal auditory canal may lead to tinnitus and hearing loss 39,40. Vestibular 
schwannomas, or acoustic neuromas, arise from the Schwann cells surrounding the eighth 
cranial nerve, resulting in both hearing loss and tinnitus as well as vertigo and disturbances 
in balance 41. Patients with a strong suspicion for acoustic neuroma should undergo 
contrast-enhanced imaging to both make a diagnosis as well as to monitor the growth of the 
tumor, which tends to be slow 42. The surgical resection of acoustic neuromas may also 
result in hearing loss and tinnitus from direct damage to the auditory nerve 43. 
Involvement of the cerebral cortex and brainstem through tumors and infarctions may result 
in subjective tinnitus. Tumors of the inferior colliculus 44 and within the cerebellopontine 
angle 45 may cause tinnitus with auditory symptoms. Infarctions of the inferior colliculus 46, 
cerebellum 47, and the basal ganglia, thalamus and pons of the cerebral cortex 48 have been 
associated with subjective tinnitus.  
There are a number of systemic illnesses that are known to cause subjective tinnitus. Anemia 
may result in a cerebral hypoxia that can cause symptoms of tinnitus, vertigo and headache, 
as in the setting of cancer-related anemia 49. Hyperlipidemia may cause or worsen tinnitus, 
and lowering blood cholesterol levels has been found to improve subjective tinnitus 50. 
Patients with low thyroid function may report some degree of hearing loss with tinnitus 51. 
Multiple sclerosis may manifest with hearing impairment with tinnitus 52,53. Syphilis may 
manifest in otologic symptoms in both early and late stages of the disease. The presence of 
otosyphilis may be characterized by hearing loss or hyperacusis with tinnitus along with 
vestibular disturbances 54. 
Medications from nearly every major category may result in ototoxicity and tinnitus. The 
use of salicylates, such as aspirin, may result in damage to the cochlea spiral ganglion 
neurons 55 and changes in cochlear NMDA receptor currents 56. Aminoglycoside antibiotics, 
such as gentamicin, are well known to cause hearing loss and vestibular damage 57. Loop 
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diuretics, such as furosemide, may result in transient or permanent ototoxicity, and these 
effects may be minimized by delivery with slow infusion rather than bolus injection or using 
divided oral doses 58. Additionally, many chemotherapeutic agents 59, heavy metals 60,61 and 
anti-malarial drugs 62,63 may contribute to hearing loss and tinnitus. 
Finally, psychiatric stressors may worsen the handicap resulting from subjective tinnitus. 
Depression 64 and fibromyalgia 65 have been found to associate with and exacerbate chronic 
tinnitus. It should be noted that subjective tinnitus generally differs from auditory 
hallucinations observed in psychotic disorders by the nature of the perceived sound; 
tinnitus generally manifests as a more simple ringing or humming, whereas auditory 
hallucinations tend to involve more complex sounds or speech 66. 
4. Diagnostic evaluation of tinnitus 
The main goal of the evaluation of tinnitus in the emergency department is to identify life-
threatening causes, preserve hearing, identify causes that are treatable, and provide the 
appropriate referral and symptomatic treatment. The initial evaluation of tinnitus begins 
with a complete history, including the onset, location, characteristics, associated symptoms, 
pattern, alleviating/exacerbating factors, past medical history and surgeries, and medication 
use. The onset of tinnitus should be characterized as sudden versus gradual. A sudden onset 
of tinnitus is concerning, and may indicate a vascular or traumatic etiology. Questions 
regarding the pattern of tinnitus should attempt to differentiate pulsatile from continuous or 
episodic tinnitus. Pulsatile tinnitus is frequently due to a vascular source whereas Ménière’s 
disease tends to be episodic. Specific associated symptoms to inquire about include hearing 
loss, vertigo, and aural fullness. The impact of patient positioning on the tinnitus should be 
asked; specifically, eustachian tube dysfunction is often alleviated by lying down. A past 
medical history of hyperlipidemia or diabetes may indicate carotid artery atherosclerosis, 
whereas a thyroid disorder or anemia may suggest a high output cause. Finally, a number of 
medications are known to cause tinnitus. 
A thorough head and neck exam should be performed on all patients presenting with 
tinnitus. A search for an objective source of tinnitus should be performed by auscultation of 
the auricular region, the mastoid, and the carotid arteries. Objective tinnitus secondary to a 
venous etiology is identified by disappearance of the sound when the ipsilateral jugular vein 
is compressed. Careful otoscopy should be performed to evaluate for middle-ear infection, 
cerumen impaction, a dehiscent jugular bulb, or glomus tumor. The oral cavity should be 
examined for contractions of the palatal muscles. The cranial nerves should be evaluated for 
evidence of hearing loss or brainstem dysfunction. Finally, a fundoscopic exam should be 
performed to look for papilledema in suspected cases of pseudotumor cerebri. 
Diagnostic testing should be guided by the results of the history and physical examination. 
A complete blood count and thyroid function tests may reveal conditions that cause 
increased cardiac output and cerebral blood flow that can result in tinnitus. Contrast 
enhanced computed tomography (CT) should be performed on patients with a tympanic 
mass visible on otoscopy, which may reveal jugular bulb abnormalities, glomus tumors, and 
vascular abnormalities. CT or MR angiography may be needed to diagnose dissecting 
aneurysms and arteriovenous fistulas. Carotid ultrasonography may confirm suspected 
carotid atherosclerotic artery disease. A lumbar puncture should be performed in patients 
who are being considered for a diagnosis of pseudotumor cerebri. The suggested approach 
to patients with tinnitus is depicted in Figures 1 and 2.  
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Fig. 1. Suggested approach to objective tinnitus in the emergency department.  
 
 
Fig. 2. Suggested approach to subjective tinnitus in the emergency department. 
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5. Management 
The management of tinnitus first involves treating identified underlying causes. Tinnitus 
secondary to ototoxic medications may resolve after discontinuing the medication. Patients 
with arteriovenous fistula or dehiscent jugular bulb may be treated with vessel ligation or 
embolization. Those with glomus tumors can be referred for surgical resection or 
angiographic embolization. Carotid endarterectomy may benefit patients with tinnitus 
secondary to carotid artery atherosclerosis if the carotid artery stenosis is greater than 60% 
67-69. Patients with benign venous hums or arterial bruits may simply need reassurance, but 
may be referred for surgical ligation of the vessel if the tinnitus causes significant reduction 
in quality of life.   
Patients with pseudotumor cerebri require intense follow-up with neurology and 
ophthalmology 70. While lumbar punctures provide temporary relief, the benefit is short-
term due to the rapid reformation of CSF and is not recommend as the primary therapy 
because of potential complications. Medical management involves treatment with carbonic 
anhydrase inhibitors, specifically acetazolamide at starting at doses of 500 mg twice daily 71. 
Loop diuretics such as furosemide (20 - 40 mg/day in adults) are an adjunctive therapy 72. 
Weight reduction also improves symptoms and is a critical component of management 73-75.    
Patients with palatal myoclonus or eustachian tube dysfunction should be referred to an 
otolaryngologist for management. Injection of botulinum toxin into the palate has been 
successful for patients with tinnitus secondary to palatal muscle myoclonus 76. Eustachian 
tube dysfunction may be managed by treatment with mucosal irritants such as tetracycline 
to the nose that cause disruption of the orifice of the eustachian tube 15; alternatively, the 
nasopharyngeal orifice may be surgically closed 77 or silicone plugs placed through the 
middle ear 78.   
Unfortunately, there are very few effective treatments specifically for tinnitus. Gabapentin 
resulted in a significant improvement in tinnitus annoyance scores for patients with tinnitus 
secondary to trauma 79, but does not appear to be effective in relieving idiopathic tinnitus 
79,80. Alprazolam was reported to decrease the loudness of tinnitus in one trial 81, whereas a 
more recent study failed to find an effect on tinnitus loudness or the Tinnitus Handicap 
Inventory 82. Clinical trials of the tricyclic antidepressant nortriptyline significantly reduced 
tinnitus, depression, and the resulting disability 83,84. However, caution should be used with 
prescribing these drugs in the emergency department due to the dangers of overdose in 
suicidal patients.  
Many experimental therapies warrant consideration in patients with tinnitus unresponsive 
to medications. The use of repetitive transcranial magnetic stimulation (rTMS) to stimulate 
regions in and around temporal auditory cortex has had some success in cases of chronic 
tinnitus 85-87. Finally, behavioral based therapies such as tinnitus retraining therapy, masking 
devices, and biofeedback therapy have reported success 10,88; consideration should be given 
to referring patients to providers who can provide these interventions.   
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